Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to determine whether concurrent treatment of patients with
major depression (unipolar or bipolar) with triiodothyronine (T3) and sertraline, will lead
to a stronger and/or more rapid antidepressant effect than treatment with sertraline alone.